| # | Country | Total Patents | |
|---|---|---|---|
| #1 | WIPO (World Intellectual Property Organization) | 7 | |
| #2 | United States | 2 | |
| #3 | Australia | 1 | |
| #4 | China | 1 | |
| #5 | EPO (European Patent Office) | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry | |
| #3 | Biotechnology | |
| #4 | Measurement | |
| #5 | Environmental technology |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Heterocyclic compounds | |
| #3 | Acyclic or carbocyclic compounds | |
| #4 | Medical preparations | |
| #5 | Peptides | |
| #6 | Climate change adaptation technologies | |
| #7 | Analysing materials | |
| #8 | Microorganisms | |
| #9 | Sugars |
| # | Name | Total Patents |
|---|---|---|
| #1 | Glick Gary | 10 |
| #2 | Roush William R | 10 |
| #3 | Ghosh Shomir | 10 |
| #4 | Shen Dong-Ming | 4 |
| #5 | Olhava Edward James | 3 |
| #6 | Glick Gary D | 2 |
| #7 | Franchi Luigi | 2 |
| #8 | Jones Roger | 1 |
| Publication | Filing date | Title |
|---|---|---|
| WO2018045204A1 | Cyclic dinucleotide analogs for treating conditions associated with sting (stimulator of interferon genes) activity | |
| WO2017184735A1 | Nlrp3 modulators | |
| US2019119241A1 | Compounds and compositions for treating conditions associated with nlrp activity | |
| WO2017040670A1 | Immune cells having increased immunity or resistance to an immunosuppressive cytokine and use of the same |